148 related articles for article (PubMed ID: 26811000)
21. Effectiveness of Vascular Markers (Immunohistochemical Stains) in Soft Tissue Sarcomas.
Naeem N; Mushtaq S; Akhter N; Hussain M; Hassan U
J Coll Physicians Surg Pak; 2018 May; 28(5):352-356. PubMed ID: 29690962
[TBL] [Abstract][Full Text] [Related]
22. [Clinical and Pathologic Features of Myeloid Sarcoma].
Jiang YJ; Wang HX; Zhuang WC; Chen H; Zhang C; Li XM; Zhu GH; He Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):926-931. PubMed ID: 28641661
[TBL] [Abstract][Full Text] [Related]
23. Gains of 12q13-14 and overexpression of mdm2 are frequent findings in intimal sarcomas of the pulmonary artery.
Bode-Lesniewska B; Zhao J; Speel EJ; Biraima AM; Turina M; Komminoth P; Heitz PU
Virchows Arch; 2001 Jan; 438(1):57-65. PubMed ID: 11213836
[TBL] [Abstract][Full Text] [Related]
24. Myeloid sarcoma: clinical and morphologic criteria useful for diagnosis.
Audouin J; Comperat E; Le Tourneau A; Camilleri-Broët S; Adida C; Molina T; Diebold J
Int J Surg Pathol; 2003 Oct; 11(4):271-82. PubMed ID: 14615822
[TBL] [Abstract][Full Text] [Related]
25. [Morphological diagnosis of myeloid sarcomas].
Leenman EE; Krivolapov IuA
Arkh Patol; 2009; 71(6):24-8. PubMed ID: 20131502
[TBL] [Abstract][Full Text] [Related]
26. Values of 5mC, 5hmC, and TET2 for identifying the presence and progression of breast precancerous lesion.
Zhang Z; Jin Y; Zhang W; Chu C; Zhang K; Gao X; Zhou J; Zou L; Tang F; Wang H; Zou Q
J Clin Lab Anal; 2020 May; 34(5):e23162. PubMed ID: 31867779
[TBL] [Abstract][Full Text] [Related]
27. Disseminated extramedullary myeloid tumor of the gallbladder without involvement of the bone marrow.
Bartley AN; Nelson CL; Nelson DH; Fuchs DA
Am J Hematol; 2007 Jan; 82(1):65-8. PubMed ID: 16947321
[TBL] [Abstract][Full Text] [Related]
28. Use of classic and novel immunohistochemical markers in the diagnosis of cutaneous myeloid sarcoma.
Amador-Ortiz C; Hurley MY; Ghahramani GK; Frisch S; Klco JM; Lind AC; Nguyen TT; Hassan A; Kreisel FH; Frater JL
J Cutan Pathol; 2011 Dec; 38(12):945-53. PubMed ID: 22050091
[TBL] [Abstract][Full Text] [Related]
29. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
Zhao F; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
[TBL] [Abstract][Full Text] [Related]
30. TET2 expression level and 5-hydroxymethylcytosine are decreased in refractory cytopenia of childhood.
Coutinho DF; Monte-Mór BC; Vianna DT; Rouxinol ST; Batalha AB; Bueno AP; Boulhosa AM; Fernandez TS; Pombo-de-Oliveira MS; Gutiyama LM; Abdelhay E; Zalcberg IR
Leuk Res; 2015 Oct; 39(10):1103-8. PubMed ID: 26277372
[TBL] [Abstract][Full Text] [Related]
31. CD34-expressing human thymocyte precursors proliferate in response to interleukin-7 but have lost myeloid differentiation potential.
Schmitt C; Ktorza S; Sarun S; Blanc C; De Jong R; Debre P
Blood; 1993 Dec; 82(12):3675-85. PubMed ID: 7505122
[TBL] [Abstract][Full Text] [Related]
32. CD7 expression on CD34+ cells from chronic myeloid leukaemia in chronic phase.
Martín-Henao GA; Quiroga R; Sureda A; García J
Am J Hematol; 1999 Jul; 61(3):178-86. PubMed ID: 10398310
[TBL] [Abstract][Full Text] [Related]
33. Decreased 5-hydroxymethylcytosine levels are associated with TET2 mutation and unfavorable overall survival in myelodysplastic syndromes.
Liu X; Zhang G; Yi Y; Xiao L; Pei M; Liu S; Luo Y; Zhong H; Xu Y; Zheng W; Shen J
Leuk Lymphoma; 2013 Nov; 54(11):2466-73. PubMed ID: 23432690
[TBL] [Abstract][Full Text] [Related]
34. TET2 Negatively Regulates Nestin Expression in Human Melanoma.
Gomes CB; Zechin KG; Xu S; Stelini RF; Nishimoto IN; Zhan Q; Xu T; Qin G; Treister NS; Murphy GF; Lian CG
Am J Pathol; 2016 Jun; 186(6):1427-34. PubMed ID: 27102770
[TBL] [Abstract][Full Text] [Related]
35. [Granulocytic sarcoma: a clinical and pathologic analysis of ten cases].
Hou ZB; Shi HY; Liang X; Wang XM
Zhonghua Bing Li Xue Za Zhi; 2012 May; 41(5):331-4. PubMed ID: 22883673
[TBL] [Abstract][Full Text] [Related]
36. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor.
Miettinen M; Lindenmayer AE; Chaubal A
Mod Pathol; 1994 Jan; 7(1):82-90. PubMed ID: 7512718
[TBL] [Abstract][Full Text] [Related]
37. Myeloid sarcoma of the maxillary bone.
Goteri G; Ascani G; Messi M; Filosa A; Segura-Egea JJ; Rubini C; Bullon P
J Oral Pathol Med; 2006 Apr; 35(4):254-6. PubMed ID: 16519776
[TBL] [Abstract][Full Text] [Related]
38. Paraffin section immunophenotyping of acute leukemias in bone marrow specimens.
Arber DA; Jenkins KA
Am J Clin Pathol; 1996 Oct; 106(4):462-8. PubMed ID: 8853033
[TBL] [Abstract][Full Text] [Related]
39. Reduction of global 5-hydroxymethylcytosine is a poor prognostic factor in breast cancer patients, especially for an ER/PR-negative subtype.
Tsai KW; Li GC; Chen CH; Yeh MH; Huang JS; Tseng HH; Fu TY; Liou HH; Pan HW; Huang SF; Chen CC; Chang HY; Ger LP; Chang HT
Breast Cancer Res Treat; 2015 Aug; 153(1):219-34. PubMed ID: 26253945
[TBL] [Abstract][Full Text] [Related]
40. Detection of SYT-SSX mutant transcripts in formalin-fixed paraffin-embedded sarcoma tissues using one-step reverse transcriptase real-time PCR.
Norlelawati AT; Mohd Danial G; Nora H; Nadia O; Zatur Rawihah K; Nor Zamzila A; Naznin M
Malays J Pathol; 2016 Apr; 38(1):11-8. PubMed ID: 27126659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
